Bioceres Crop Solutions (BIOX) Liabilities and Shareholders Equity (2017 - 2026)

Bioceres Crop Solutions has disclosed Liabilities and Shareholders Equity across 10 years of filings, most recently posting $529.6 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $529.6 million, down 33.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 billion (down 21.88% YoY), and the FY2025 annual result was $763.6 million, down 10.43% from the prior year.
• Liabilities and Shareholders Equity came in at $529.6 million for Q1 2026 at Bioceres Crop Solutions, down from $560.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $872.9 million in Q4 2022 to a low of $503.6 million in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $818.1 million (2023), against an average of $748.3 million.
• Across the five-year window, Liabilities and Shareholders Equity jumped 902.63% in 2022 and slumped 33.65% in 2026, its largest moves.
• Bioceres Crop Solutions' Liabilities and Shareholders Equity stood at $872.9 million in 2022, then decreased by 6.11% to $819.5 million in 2023, then increased by 1.91% to $835.2 million in 2024, then sank by 32.91% to $560.4 million in 2025, then slipped by 5.49% to $529.6 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $529.6 million (Q1 2026), $560.4 million (Q4 2025), and $734.9 million (Q3 2025), per Business Quant data.